BQ 788Alternative Names: BQ788
Latest Information Update: 17 Sep 2004
At a glance
- Originator Banyu
- Mechanism of Action Endothelin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 08 Aug 2002 Discontinued - Preclinical for Hypertension in USA (unspecified route)
- 10 Feb 2000 Preclinical trials in Hypertension in USA (unspecified route)